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We performed a retrospective study examining the prevalence and subtypes of pulmonary emphysema 
(PE) identiﬁed by computed tomography (CT) in females.  We reviewed the records of 1,687 female 
subjects who had undergone CT.  They were divided into the following 2 age groups: group A (＜50 
years) and group B (ｧ50 years).  PE was diagnosed by the presence of low-attenuation areas using 
visual assessment (grades 0-3) on CT images.  Two subtypes of PE were observed: centrilobular 
emphysema (CLE) and paraseptal emphysema (PSE).  PE was divided into the following 3 
categories: I (CLE or CLE-predominant); II (CLE and PSE of equal extent); and III (PSE or PSE-
predominant).  PE was found in 64 of 274 smokers (23.3ｵ) and 54 of 1,413 non-smokers (3.8ｵ).  In 
smoking subjects,  when grades 1 and 2 were grouped together as mild PE,  the mean age for CT grade 
3 (severe PE) was signiﬁcantly higher than that for mild PE.  In group A,  category III predominated,  
whereas category I was more prevalent in group B,  in both smoking and non-smoking subjects.  A high 
incidence of PE was found in smoking subjects as compared with non-smoking subjects.  PSE predomi-
nated in younger subjects,  whereas CLE predominated in older subjects.
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ulmonary emphysema (PE) is deﬁned by the 
American Thoracic Society as an abnormal,  
permanent enlargement of the airspaces distal to the 
terminal bronchioles,  accompanied by destruction of 
their walls,  most often caused by chronic obstructive 
pulmonary disease (COPD) or alpha1-antitrypsin 
deﬁciency [1,  2].  PE is one of the most important 
diseases related to cigarette smoking,  and smoking 
causes a large proportion of cases of PE.  Computed 
tomography (CT) is currently the method of choice for 
noninvasive assessment of pathologic changes of the 
alveoli in emphysema,  and a high correlation with 
histopathology has been shown [3,  4].
　 Based on an epidemiologic study,  Fukuchi et al.  
reported that in Japan the prevalence of COPD in the 
population of smokers older than 40 years was 10.9ｵ 
overall (men: 16.4ｵ; women: 5.0ｵ) [5].  In addi-
tion,  it has been reported using CT that PE is 
observed in more than half of male Japanese smokers 
[6].  Whether or not females are more susceptible to 
cigarette smoke than males is controversial [7,  8].  
The purpose of the present study was to assess the 
prevalence and subtypes of PE identiﬁed by CT imag-
ing in females.
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Subjects and Methods
　 Subjects. We reviewed the records of 1,687 
female subjects (ranging in age from 25 to 94 years) 
who had undergone CT scanning at our University 
Hospital between March 2002 and December 2006 
because of suspected lung disease seen on chest radio-
graphs or because of respiratory complaints.  Of the 
1,687 subjects,  274 were smokers (16.2ｵ) and 1,413 
were non-smokers (83.8ｵ).  Ex-smokers were included 
with smokers.  The level of serum alpha 1-antitrypsin 
was not checked because its deﬁciency is very rare in 
Japan.  Subjects were divided into the following 2 age 
groups: group A (＜50years); and group B (ｧ50 
years).  Institutional review board exemption was 
obtained,  and informed consent was not required.
　 CT examination. Two CT machines (Aqui-
lion; Toshiba; Tokyo,  Japan [used at 120kV and 300 
mA] and HiSpeed Advantage RP; Yokogawa; Tokyo,  
Japan [used at 120kV and 240mA]) were used.  In all 
cases,  contiguous 1-cm sections encompassed the 
entire thorax.   Hard-copy images were photographed 
at a 1600-Hounsﬁeld unit (HU) window width and a 
-800-HU window level (Aquilion,  Toshiba) and at a 
1,500-HU window width and a -700-HU window level 
(HiSpeed Advantage RP).
　 CT image analysis. PE was diagnosed on the 
basis of the presence of low-attenuation areas (LAAs) 
on CT images using visual assessment.  The CT 
images were evaluated independently by 2 experienced 
radiologists who did not have information as to 
whether the subject was from the group of smokers or 
non-smokers.  Any diﬀerence of opinion was resolved 
by consensus.
　 According to the extent of LAAs in the peripheral 
lung ﬁelds,  the CT ﬁndings were classiﬁed into the 
following four grades: grade 0 (no LAAs); grade 1 
(sparse,  scattered small LAAs up to 5mm in 
diameter); grade 2 (adjacent LAAs up to 10mm in 
diameter); and grade 3 (LAAs＞10mm that were 
adjacent to or indistinguishable from each other) [9].  
　 PE is usually classiﬁed into the following 3 main 
subtypes: centrilobular emphysema (CLE); panlobular 
emphysema (PLE); and paraseptal emphysema (PSE) 
[10].  In the present study,  there were no subjects 
with PLE.  Therefore,  PE was classiﬁed into the 
following 3 categories based on the presence of CLE 
and PSE: I (CLE or CLE-predominant); II (CLE and 
PSE of equal extent); and III (PSE or PSE-
predominant).   
　 Statistics. Diﬀerences between groups were 
analyzed by Studentʼs t test or the chi-square test.  
Signiﬁcance was determined at the p＜0.05 level.
Results
　 Table 1 shows the prevalence of PE detected by 
CT.  Of the total of 1,687 female subjects,  PE was 
present in 118 (7.0ｵ).  PE was found in 64 of 274 
smokers (23.3ｵ) and 54 of 1,413 non-smokers (3.8ｵ).  
In non-smokers with PE,  none had a previous diagno-
sis of collagen diseases.  The prevalence of PE was 
signiﬁcantly higher in smokers than non-smokers (p＜
0.0001).   There was no signiﬁcant diﬀerence between 
mean (±SD) age in smoking (63.5±15.2) and non-
smoking (65.2±14.3) subjects with PE.  The percent-
age of subjects with PE increased with age.
　 There were no signiﬁcant diﬀerences between CT 
grade and mean (±SD) age in smoking and non-smok-
ing subjects (Table 2).  However,  when grades 1 and 2 
in smokers were grouped together as mild PE,  the 
mean (±SD) age for CT grade 3 (severe PE) (69.1±
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Table 1　 Prevalence of PE detected by CT in 1,687 female subjects according to age group
Age group Smoking status Subjects with PE/total %
Group A (＜50 years) Smoker  11/61 18.0
Non-smoker 　7/230 3.0
Group B (ｧ50 years) Smoker  53/213 24.9
Non-smoker  47/1,183 4.0
All subjects Smoker  64/274 23.3
Non-smoker  54/1,413 3.8
Total 118/1,687 7.0
PE,  pulmonary emphysema.
9.4) was signiﬁcantly higher than that for mild PE 
(61.2±16.2) (p＜0.05).  In smokers,  there were no 
statistically signiﬁcant diﬀerences in smoking indices 
according to CT grade within each age group (Table 
3).  In 64 smoking subjects with PE,  although there 
was also no statistically signiﬁcant diﬀerence in smok-
ing indices between group A (16.4±3.4) and group B 
(33.9±4.5) (p=0.08),  the smoking indices of group B 
tended to be higher than those of group A.
　 In group A,  category III predominated (Fig.  1),  
whereas category I was more prevalent in group B 
(Fig.  2),  in both smoking and non-smoking subjects 
(Table 4).  There was a statistically signiﬁcant diﬀer-
ence between subjects in groups A and B (p＜0.05) 
among both smokers and non-smokers especially with 
respect to the prevalence of subjects in categories I 
and II combined and the prevalence of subjects in 
category III in each age group.  
Discussion
　 In the present study comprising 1,687 female sub-
jects,  a high incidence of PE was found in smoking 
subjects (23.3ｵ) as compared with non-smoking sub-
jects (3.8ｵ).  Smoking in female subjects may be an 
important cause of PE.  The percentage of subjects 
with PE increased with age.  Furthermore,  the mean 
age of the severe PE group was signiﬁcantly higher 
than that of the mild PE group.  The prevalence of 
CLE was greater in older females.
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Table 2　 CT grades of PE and age in 64 smoker and 54 non-smoker subjects with PE
Smoking Status CT Grade
1 2 3
Smokers n 30 17 17
Age,  mean±SD (years) 57.4±18.6 66.1±16.3 69.1±9.4
Non-smokers n 33 12  9
Age,  mean±SD (years) 67.8±14.2 60.9±14.8 61.6±10.8
PE,  pulmonary emphysema.
Table 3　 CT grades of PE and smoking indices in 64 smoker subjects with PE
Smokers CT Grade  
1 2 3
Group A n  8  3  0
Smoking,  mean±SD,  Pack-years 16.7±11.7 15.7±8.2
Group B n 22 14 17
Smoking,  mean±SD,  Pack-years 30.2±28.1 29.6±33.4 43.9±33.2
PE,  pulmonary emphysema.  One pack-year: 1 package of cigarettes (20 cigarettes) daily for one year.
Table 4　 Category subtypes of PE in 64 smoker and 54 non-smoker subjects with PE
Smoking Status Category Subtype
I II III
Smokers Group A n (%)  4 (36.4) 0  7 (63.6)
Group B n (%) 36 (67.9) 4 (7.5) 13 (24.5)
Non-smokers Group A n (%)  2 (28.6) 0  5 (71.4)
Group B n (%) 29 (61.7) 3 (6.4) 15 (31.9)
PE,  pulmonary emphysema.
　 Omori et al.  have reported that among Japanese 
male subjects undergoing annual health care examina-
tions the prevalence of PE was 30.5ｵ in current 
smokers and 3.0ｵ in non-smokers [11].  Camiciottoli 
et al.  reported that the prevalence of PE was 30.3ｵ 
in male smokers and 19.8ｵ in female smokers [12].  
Autopsy studies have reported an increase in the 
incidence of PE with age [13].  Hatayama et al.  
reported that the mean age of the mild PE group was 
higher than that in the subtle PE group [14].  These 
ﬁndings are consistent with the present study.
　 In the present study,  we found no correlation 
between the number of packs of cigarettes smoked per 
year (packs/year) and the severity of PE.  This 
appears to be counterintuitive,  because cigarette 
consumption is clearly a major risk factor for the 
development of PE,  as the severity of PE increases 
with the number of cigarettes smoked [15, 16].  
However,  similar results have also been previously 
reported [17].  Although Wang et al.  found a distinct 
correlation between smoking and the prevalence of PE,  
indexes of smoke exposure did not correlate with the 
extent of CT abnormalities [18].  Gillooly and Lamb 
also reported no correlation between smoking habits 
and the extent of microscopic emphysema [19].
　 Chen et al.  showed that cigarette consumption may 
be more detrimental in its eﬀects on lung function in 
women than in men [20].  Langhammer et al.,  in a 
survey of more than 65,000 men and women in 
Norway,  noted that,  of current and previous smokers,  
women were signiﬁcantly more likely than men to 
report respiratory symptoms and asthma,  even after 
the authors controlled for packs/year of smoking and 
current levels of cigarette smoking per day [21].  
This study concluded that women seemed to be more 
susceptible to the eﬀect of tobacco smoking than men 
[21].
　 The prevalence of CLE was greater in older 
females in the present study.  This result is similar to 
that of a previous study in which the prevalence of 
CLE was reported to rise with age [6].  CLE was 
reported to be the most common form of PE and has a 
proven association with cigarette smoking [1, 11].  
PSE can occur as an isolated phenomenon in young 
adults [1].  However,  category III (PSE or PSE-
predominant) PE in the present study was found not 
only in younger subjects but also in older subjects.  
Satoh et al.  reported a high incidence of PSE in 
younger male smoking subjects [6].  The pathogenesis 
of emphysema is often explained by the hypothesis of 
an imbalance between locally acting proteolytic and 
anti-proteolytic mechanisms within the lungs [22].  
Lysosomal enzymes released by neutrophils and mac-
rophages during an inﬂammatory reaction can damage 
the lung parenchyma [22].  However,  PSE is not well 
understood.  Pleural pressure gradients might be 
important.  There are isolated case reports describing 
early-onset emphysema in young patients without a 
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Fig. 1　 CT image of a subject with grade 2,  category III PE in 
age group A (a 46-year-old female non-smoker).  LAAs adjacent to 
the chest wall are seen.
LAAs=low-attenuation areas
Fig. 2　 CT image of a subject with grade 3,  category I PE in age 
group B (a 68-year-old female,  with cigarette consumption of 40 
pack-years).  LAAs＞10mm in diameter fuse with each other in the 
whole of the upper and middle lung ﬁelds.  
LAAs=low-attenuation areas
signiﬁcant smoking history and with a normal alpha-1-
antitrypsin level [23, 24].  These reports suggest that 
other genetic and environmental risk factors may also 
play role in the development of emphysema.  PSE 
occurs in young adults who are tall and thin.  It is 
characterized as an enlarged airspace at the periphery 
of the acini [25].  The lesion is usually limited in 
extent and occurs most commonly along the dorsal 
surface of the upper lung.  PSE patients are asymp-
tomatic,  but the condition is considered to be a cause 
of pneumothorax in young adults [25].
　 In the present study,  a signiﬁcantly higher preva-
lence of PE was seen in smokers than non-smokers.  
Nonetheless,  PE was found in 3.8ｵ of non-smokers.  
A similar rate of occurrence of PE in non-smokers 
was also reported by Wang [18].  Involuntary expo-
sure to environmental tobacco smoke is also serious 
and an entirely preventable public hazard.  It has 
become clear that environmental tobacco smoke 
adversely aﬀects the health of all who breathe in its 
toxins.  Independent of active smoking,  environmental 
tobacco smoke exposure is a modiﬁed risk factor for 
COPD and lung cancer [26, 27].  Simoni and cowork-
ers reported that environmental tobacco smoke expo-
sure is a risk factor for respiratory health in women 
who have never been smokers [8].
　 Smoking groups are deﬁned as follows: ʻnever 
smokers,ʼ ʻex-smokers,ʼ and ʻcurrent smokers.ʼ In the 
present study,  the non-smoking subjects were ʻnever 
smokersʼ according to their medical records.  
However,  the present study did not evaluate whether 
or not the non-smoking subjects had been exposed to 
environmental smoke.  Further studies that account for 
passive smoking are required to evaluate the incidence 
of PE in female subjects.
　 The present ﬁndings suggest that CT detects PE 
at an early stage.  The percentage of subjects with PE 
increased with age.  The provision of a smoking cessa-
tion program for young female subjects with PE 
should be considered an important strategy to help 
prevent progression of the disease.
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